Non-genetic mechanisms of diabetic nephropathy

被引:0
作者
Qiuxia Han
Hanyu Zhu
Xiangmei Chen
Zhangsuo Liu
机构
[1] Beijing Key Laboratory of Kidney Diseases,Department of Nephrology, Chinese PLA General Hospital, Chinese PLA Institute of Nephrology, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases
[2] The First Affiliated Hospital of Zhengzhou University,Department of Nephrology
来源
Frontiers of Medicine | 2017年 / 11卷
关键词
diabetic nephropathy; immune inflammatory response; epithelial–mesenchymal transition; apoptosis; mitochondrial damage; epigenetics; podocyte–endothelial communication;
D O I
暂无
中图分类号
学科分类号
摘要
Diabetic nephropathy (DN) is one of the most common microvascular complications in diabetes mellitus patients and is characterized by thickened glomerular basement membrane, increased extracellular matrix formation, and podocyte loss. These phenomena lead to proteinuria and altered glomerular filtration rate, that is, the rate initially increases but progressively decreases. DN has become the leading cause of end-stage renal disease. Its prevalence shows a rapid growth trend and causes heavy social and economic burden in many countries. However, this disease is multifactorial, and its mechanism is poorly understood due to the complex pathogenesis of DN. In this review, we highlight the new molecular insights about the pathogenesis of DN from the aspects of immune inflammation response, epithelial–mesenchymal transition, apoptosis and mitochondrial damage, epigenetics, and podocyte–endothelial communication. This work offers groundwork for understanding the initiation and progression of DN, as well as provides ideas for developing new prevention and treatment measures.
引用
收藏
页码:319 / 332
页数:13
相关论文
共 798 条
  • [1] Kanwar YS(2011)A glimpse of various pathogenetic mechanisms of diabetic nephropathy Annu Rev Pathol 6 395-423
  • [2] Sun L(2013)Epigenetic modifications in the pathogenesis of diabetic nephropathy Semin Nephrol 33 341-353
  • [3] Xie P(2011)Kidney biopsy in patients with diabetes mellitus Clin Nephrol 76 180-185
  • [4] Liu FY(2010)Renal Pathology Society. Pathologic classification of diabetic nephropathy J Am Soc Nephrol 21 556-563
  • [5] Chen S(2016)Trends in chronic kidney disease in China N Engl J Med 375 905-906
  • [6] Reddy MA(2014)Diabetic nephropathy and inflammation World J Diabetes 5 393-398
  • [7] Tak Park J(2013)Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis Front Endocrinol (Lausanne) 4 7-665
  • [8] Natarajan R(2015)The expression of tristetraprolin and its relationship with urinary proteins in patients with diabetic nephropathy PLoS One 10 e0141471-152
  • [9] Haider DG(2015)Relevance of TNF-α in the context of other inflammatory cytokines in the progression of diabetic nephropathy Kidney Int 88 662-742
  • [10] Peric S(2013)Inflammation and the pathogenesis of diabetic nephropathy Clin Sci (Lond) 124 139-F731